Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth
Update your Virtual Booth on PharmaCompass, ask us
About
CPhI Worldwide, MilanCPhI Worldwide, Milan
Not Confirmed
Not Confirmed
08-10 October, 2024
BioProcess Internation...BioProcess International
Not Confirmed
Not Confirmed
22-26 September, 2024
SPE Annual TechnicalSPE Annual Technical
Not Confirmed
Not Confirmed
23-25 September, 2024
List your booth number for exhibitions, ask us
CONTACT DETAILS
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Events
Webinars & Exhibitions
CPhI Worldwide, MilanCPhI Worldwide, Milan
Industry Trade Show
Not Confirmed
08-10 October, 2024
BioProcess Internation...BioProcess International
Industry Trade Show
Not Confirmed
22-26 September, 2024
SPE Annual TechnicalSPE Annual Technical
Industry Trade Show
Not Confirmed
23-25 September, 2024
Digital content
INTERVIEW #SpeakPharma
[Sponsored by another company]https://www.pharmacompass.com/speak-pharma/we-re-unlocking-life-changing-potential-in-complex-molecules-without-sacrificing-time-to-market
VLOG #PharmaReel
[Sponsored by another company]DATA COMPILATION #PharmaFlow
[Sponsored by another company]https://www.pharmacompass.com/radio-compass-blog/bms-bayer-takeda-pfizer-downsize-to-combat-cost-pressures-meet-restructuring-plans
13 Sep 2024
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/live-from-esmo-2024--ascentage-pharma-releases-latest-data-showing-sustained-clinical-efficacy-of-olverembatinib-in-sdh-deficient-gist-during-a-mini-oral-presentation-302248193.html
08 Sep 2024
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/esmo-2024--ascentage-pharma-to-present-updated-data-of-olverembatinib-in-patients-with-sdh-deficient-gist-during-a-mini-oral-presentation-at-the-2024-esmo-congress-302241379.html
22 Aug 2024
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/ascentage-pharma-announces-2024-interim-results-302228775.html
12 Aug 2024
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/registrational-phase-iii-study-of-lisaftoclax-in-newly-diagnosed-patients-with-higher-risk-myelodysplastic-syndrome-cleared-by-china-cde-302220510.html
07 Jul 2024
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/olverembatinib-approved-for-commercialization-in-macau-china-302190451.html
03 Jul 2024
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/ascentage-pharma-received-us100-million-option-payment-from-takeda-302189330.html
ABOUT THIS PAGE
LOOKING FOR A SUPPLIER?